EPCLUSA
Identification of Epclusa
| No description |
Google image searchProduct monograph
Active ingredients
sofosbuvir, 400 MG
velpatasvir, 100 MG
DIN: 02456370
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
Date: 02-AUG-2016
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AP — Antivirals for treatment of HCV infections (ATC, ATC/DDD)
- J05AP55 — SOFOSBUVIR AND VELPATASVIR (ATC/DDD)
Reference brand drug: Epclusa, Epclusa
